Academic researchers from King's College London have investigated the early effects of an immunosuppressant drug that could help clinicians with future personalized approaches for the treatment of psoriasis.
Feb 19, 2024
0
19
New research by the University of Sussex could help to increase life expectancy and improve treatment for an aggressive brain cancer, which impacts thousands of people every year in the UK, and hundreds of thousands worldwide.
Feb 15, 2024
0
51
A large national study has found that video visits, texting and mailing pills are all effective, as the U.S. Supreme Court considers limiting access to telemedicine abortion.
Feb 15, 2024
0
5
It was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working.
Feb 14, 2024
0
13
Taking an anticoagulant, or blood-thinning medication, can increase one's risk of—or exacerbate—a brain bleed, also known as a brain hemorrhage, which is the deadliest type of stroke. Now, new research finds that faster ...
Feb 14, 2024
0
11
A research team has successfully incorporated anti-inflammatory drugs into a hydrogel to suppress inflammation in the retina and effectively deliver the drugs to the inflamed area.
Feb 14, 2024
0
54
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...
Feb 13, 2024
0
8
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and Thayer School of Engineering and published in Cell Reports Medicine offer new insights into how antibodies function ...
Feb 12, 2024
0
66
A team of University of Michigan researchers has developed a multimodal AI model to predict treatment outcomes of tuberculosis (TB) patients. Their analysis of worldwide patient data may lead to personalization of TB treatment.
Feb 12, 2024
0
26
